Search

everythinglearnresearchcommunity

for

Search:↓

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Vitamin D might help treat alopecia areata.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Injectable platelet-rich fibrin therapy improved hair and scalp conditions in women with excessive hair loss.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Dupilumab may cause hair loss, so patients should be monitored.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Both treatments for alopecia areata showed similar modest effectiveness.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

The summit aimed to speed up finding treatments for alopecia areata.

LED therapy may improve skin health and stimulate hair growth.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.